M&A Deal Summary

Claritas Pharmaceuticals Acquires Talent Biotechs

On February 16, 2017, Claritas Pharmaceuticals acquired life science company Talent Biotechs for 10M USD

Acquisition Highlights
  • This is Claritas Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Claritas Pharmaceuticals’ largest (disclosed) transaction.
  • This is Claritas Pharmaceuticals’ 1st transaction in Israel.

M&A Deal Summary
Date 2017-02-16
Target Talent Biotechs
Sector Life Science
Buyer(s) Claritas Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 10M USD

Target

Talent Biotechs

Bnei Brak, Israel
Talent Biotechs Ltd. is an Israeli-based company evaluating the use of CBD to prevent and treat Graft versus Host Disease (“GvHD”).

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Claritas Pharmaceuticals

San Rafael, Massachusetts, United States
Category Company
Founded 2014
Sector Life Science
DESCRIPTION

Claritas Pharmaceuticals is a developer of proprietary cannabidiol (“CBD”) therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. Claritas Pharmaceuticals was founded in 2014 and is headquartered in San Rafael, California.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
Country (Israel) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-19 Salzman Group

West Tisbury, Massachusetts, United States

Salzman Group, Inc. is a global drug development company that seeks to transform medical practice by undertaking transformative pharmaceutical innovation. As an organization, Salzman Group prides itself on a high-energy culture of accountability, teamwork, and creativity. Salzman Group was formed in 1996 and is based in West Tisbury, Massachusetts.

Buy -
Mergr

Product

Company

Legal